Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
  • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
  • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
  • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
  • C07C29/149—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof with hydrogen or hydrogen-containing gases
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
  • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
  • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
  • B01J31/189—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms containing both nitrogen and phosphorus as complexing atoms, including e.g. phosphino moieties, in one at least bidentate or bridging ligand
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
  • B01J2231/60—Reduction reactions, e.g. hydrogenation
  • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
  • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
  • B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
  • B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
  • B01J2531/0255—Ligands comprising the N2S2 or N2P2 donor atom set, e.g. diiminodithiolates or diiminodiphosphines with complete pi-conjugation between all donor centres
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
  • B01J2531/82—Metals of the platinum group
  • B01J2531/821—Ruthenium

Definitions

• the present invention relates to fragrance ingredients and methods of forming same.
• RosalvaTM (9-decenol) is an example of such an interesting fragrance ingredient, which is highly desirable for its floral-rosy-fatty aldehydic smell.
• the chemistry into such interesting fragrant alcohols might involve the catalytic hydrogenation of a corresponding ester to produce the alcohol.
• WO2006106483 discloses a class of bidentate ruthenium (I I) complexes that are useful in the catalytic hydrogenation of esters and WO 2013023307 discloses a class of tridentate complexes for this purpose.
• WO2006106484 discloses a class of tetradentate ruthenium complexes that are useful in the catalytic hydrogenation of esters.
• ester e.g. methyl or ethyl decenoate
• corresponding ester contains a carbon-carbon double bond that would be susceptible to competitive hydrogenation.
• I ndeed owing to its position on the terminus of the carbon chain, this double bond might be considered to be particularly labile.
• the invention addresses the problems with the prior art and provides in a first aspect a process for the chemoselective reduction of a terminally unsaturated carboxylic ester (I) to a terminally unsaturated alcohol (II) by catalytic hydrogenation, in particular, in the presence of a transition metal complex, more particularly a ruthenium (I I) complex
• A is a divalent radical containing 1 to 30 carbon atoms, which may be linear or branched, substituted or unsubstituted aliphatic, aromatic or contain both aliphatic and aromatic elements;
• R is a hydrocarbon radical or a radical derived from a hydrocarbon, which may be substituted or unsubstituted and saturated or unsaturated;
• Ri is a hydrogen atom or a Ci_ 20 linear or branched, substituted or unsubstituted alkyl or alkene group; and m is an integer from 1 to 6.
• radical A is an aromatic radical, or contains aromatic elements, it may contain one or a multiple of aromatic rings, and any aromatic rings may contain heteroatoms, including N, O or S-atoms.
• the radical R is selected from a linear or branched, saturated or unsaturated, substituted or unsubstituted Ci_ 20 hydrocarbon group.
• the substituent may be selected from any of those substituents referred to hereinabove.
• the radical R is methyl, ethyl, linear or branched propyl or linear or branched butyl. More particularly, the radical R is ethyl.
• the invention provides a process for the chemoselective reduction of a terminally unsaturated carboxylic ester to a terminally unsaturated alcohol by catalytic hydrogenation, in particular, in the presence of a transition metal complex, more particularly a ruthenium (I I) complex
• R, Ri and m are as herein defined, and wherein n is an integer from 1 to 10.
• R is methyl or ethyl, m is 1. More particularly still, R is methyl or ethyl, m is 1, and n is 7 or 8.
• the carboxylic ester is methyl 9-decenoate, ethyl 9-decenoate, methyl 10-undecenoate or ethyl 10-undecenoate.
• the carboxylic ester is ethyl 9-decenoate or ethyl 10-undecenoate.
• radical R may be a di-, tri- or multi-valent hydrocarbon radical or radical derived from a hydrocarbon.
• the radical R may be such that the ester of formula la is represented by the formula
• p is zero or an integer from 1 to 4 and n and Ri are as hereinabove defined. More particularly, p is zero or 1. Still more particularly, p is zero or 1 and n is 7 or 8.
• a characteristic of all the carboxylic esters I that can serve as starting substrates in a process according to the invention is that they contain a carbon-carbon double bond at the terminus of a chain.
• Mono-or di-substituted alkene groups such as these are believed to be particularly labile and therefore more susceptible to compete with the ester double bond during hydrogenation.
• the process proceeds in the presence of a homogeneous ruthenium (II) complex.
• the ruthenium complex employed in the present invention may be any of those complexes disclosed in WO2006106484, which document, for the purpose of disclosing the ruthenium complexes contained therein, is hereby incorporated by reference.
• the ruthenium(ll) complex is a complex with a tetradentate ligand wherein the coordinating groups of said ligand consist of at least one imino or amino group and at least one phosphino group.
• suitable catalysts are described in WO2006106484.
• the ruthenium complex is represented by the formula 4a or 4b whose syntheses has been reported by Gao et al. in Polyhedron 15, 1241, 1996.
• esters referred to hereinabove can be converted completely or nearly completely to their alkenols II, with a significantly improved chemoselectivity towards ester hydrogenation.
• An improved chemoselectivity in ester hydrogenation means that side reactions such as alkene hydrogenation and / or alkene isomerization are substantially suppressed.
• the reaction proceeds with high chemoselectivity with complete or substantially complete conversion of the ester functionality, e.g. > 80 %, more particularly > 85%, more particularly > 90%, more particularly > 95%, and still more particularly 99 - 100 %, of the ester functionality is converted.
• the substrate (starting material)/catalyst ratio can influence the chemoselectivity and conversion of the reaction of present invention.
• the substrate/catalyst ratio is greater than 2000, more particularly greater than 10000, still more particularly greater than 20000, wherein the ratio is a molar ratio.
• the amount of ruthenium (II) complex employed can affect the extent of conversion of the carboxylic esters, as well as the chemoselectivity of the reaction such that high levels of the complex tend to promote a fast and complete conversion of the terminally unsaturated carboxylic ester, but chemoselectivity may be compromised.
• substrate (I) is either an ethyl ester or a higher ester, for example n-propyl, / ' so-propyl, n-butyl, iert-butyl, so-butyl or even higher branched and unbranched esters.
• Metal alkanoates are preferred bases for use in the present invention.
• the metals may be Na, K or Cs; whereas the alkanoates may be C x to Ci 0 alkanoates, which may be linear or branched.
• the metal alkanolate may be used in any amounts between 1 mol-equivalent per substrate and and 1 mol-equivalent per catalyst, but typically in amounts of 5 - 15% per substrate to obtain reproducible results and to keep the cost contribution of the base low.
• the solvent employed in the base/solvent system can be any solvent that is typically employed in homogeneous catalytic hydrogenation reactions.
• Non-limiting examples of solvents include aromatic solvents such as toluene or xylenes; hydrocarbon solvents such as hexane or cyclohexane; ethers such as tetrahydrofuran or MTBE; and polar solvents such as te/t-butanol.
• aromatic solvents such as toluene or xylenes
• hydrocarbon solvents such as hexane or cyclohexane
• ethers such as tetrahydrofuran or MTBE
• polar solvents such as te/t-butanol.
• Preferred solvents are ethers or furanes such as THF or analogues such as cyclopentyl methyl ether (CPME), methyltetrahydrofurane, but any acyclic or cyclic polyethers such as dioxane or tetraethyleneglykoldiethyl ether can be also used. More particularly, the reaction proceeds with high chemoselectivity and with complete or substantially complete conversion of the ester functionality if low levels of solvent, or even solvent-free systems are employed. Low levels of solvent include ⁇ 100% solvent per substrate in weight equivalents (w/w), ⁇ 50% w/w, ⁇ 25% w/w or preferable ⁇ 10% w/w.
• a sacrificial terminal alkene may be employed in the reaction mixture.
• the substrate/catalyst ratio, the nature of the ester substituent , and the nature of the base / solvent system can positively influence the efficiency and the ester-selective catalytic homogeneous hydrogenation of terminally unsaturated esters such as I and II, it is nevertheless desirable to avoid hydrogenation of the terminal double bond after the ester function has been reduced.
• R and R" can be H, or optionally substituted alkyl, alkenyl, or aryl.
• R' and R" can be bound together to form a ring system or ring systems. The ring system or systems can be optionally substituted.
• the substituent can contain any of the main group elements such as O, S or N. More specifically the terminal alkene (III) is chosen from any terminal C 6 - C 30 alkene, diene, triene or polyene, all of which may be substituted or unsubstituted.
• the unsaturation can be conjugated such as in isoprene, myrcene, farnesene, or part of an aromatic system as in styrene, all optionally substituted.
• the sacrificial alkene When employed, the sacrificial alkene may be added in amounts of 0.1 - 10 mol-equiv, ideally in amounts of 0.2 - 3 mol equiv.
• the molecular weight of the sacrificial alkene is chosen as such that it can be easily separated from the hydrogenation product by distillation.
• Monosubstituted alkene or ⁇ , -disubstituted methylene additives (III) can be chosen from any terpene compound, such as limonene, or can be in conjugation with other double bonds, such as in isoprene or myrcene, or can be in conjugation with aromatic systems (such as in oc- methylstyrene).
• the sacrificial alkene III used in this invention is selected such that it is a low viscosity liquid. As such, it can act as a solvent and can be used to dissolve and aid the addition of catalyst to the substrate without using any other solvent. With the sacrificial alkene acting in this fashion, the hydrogenation can be carried out therefore under essentially solvent-free conditions and under industrial conditions which allow addition of the catalyst in a solvent.
• ester intermediate Ilia is a sacrificial alkene.
• This intermediate is formed and accumulated during the process of the present invention by transesterification of substrate I with reduced alkenol product II and undergoes reduction, in case of lower reactivity of I lia compared to I, when I has been completely consumed.
• the process of the present invention proceeds by employing a substrate/catalyst ratio greater than 2000; and/or employing an ester substrate (I) which is an ethyl ester or higher ester as defined herein above; and/or employing an efficient base/solvent system such as NaOMe/toluene or KOMe/THF; and or employing a sacrificial alkene as hereinabove defined.
• an ester substrate (I) which is an ethyl ester or higher ester as defined herein above
• an efficient base/solvent system such as NaOMe/toluene or KOMe/THF
• a sacrificial alkene as hereinabove defined.
• transition metal complexes employed for this reaction e.g. the ruthenium (II) complexes 4a or 4b may not itself be catalysts in the homogeneous catalytic reduction of carboxylic esters with hydrogen.
• any carbon of the ligand of catalysts 4 can be optionally substituted.
• the reaction may be carried out in an autoclave at a H 2 pressure ranging from 1 to 80 bars, or even higher, more particularly 40 to 80 bar or higher.
• H 2 pressure may be adjusted to optimise for the level of complex used.
• the temperature at which the reaction may be carried out may vary depending on such factors as the melting/boiling point, the viscosity and the polarity of the substrate employed and the reaction products as well as the desired reaction time to achieve full, or substantially full conversion. Typically, however, the reaction will be carried out between 50 and 120 degrees centigrade.
• Non-commercial ester substrates were purified by flash chromatography and / or distillation before use.
• Non-polar GCMS 50 °C / 2 min, 20 °C/ min 200 °C, 35 °C / min 270 °C.
• GCMS Agilent 5975C MSD with HP 7890A Series GC system.
• Non-polar column BPX5 from SGE, 5 % phenyl 95% dimethylpolysiloxan 0.22 mm x 0.25 mm x 12m.
• Carrier Gas Helium.
• Injector temperature 230 °C.
• Split 1 50.
• Flow 1.0 ml/min. Transfer line:250 °C.
• MS-quadrupol 106 °C.
• MS-source 230 °C.
• toluene (3 ml) is added to a glass vial (50 ml) containing uCI 2 (PN NP) catalyst 4a (2.5 mg, 0.01 mol%) and NaOMe (0.163 g, 3 mmol).
• the suspension is treated in an ultrasonic bath until a reddish solution is obtained (3 - 5 min) to which a solution of ethyl 10-undecenoate (6.4 g, 29 mmol) in toluene (18 ml) is added.
• the vial is capped (crimp cap & silicone septum), punctured with a needle and put in a Parr autoclave.
• the analytical data of 10-undecenol 2a, undecanol 2b and methyl undecanoate 2c are identical with the ones obtained from commercial samples of these compounds.
• the analytical data of 9- undecenol 2d (partially in J.Organomet.Chem.691, 5278, 2006 and references) and undecenoic acid undecenyl ester 3 (Tetrahedron 63, 11325, 2007) were identical with the ones described in the literature.
• RuCI 2 (PNNP) catalyst 4a (7.5 mg, 0.01 mol%) in toluene (5 ml) are treated 5 min with ultrasound to give a fine suspension which is added to a suspension of ethyl 10-undecenoate lb (19.2 g, 90 mmol) and NaOMe (0.5 g, 9 mmol) in toluene (16 ml) in a 120 ml Premex autoclave under argon. The autoclave is flushed three times with hydrogen and then heated at 100 °C under 50 bar hydrogen and 1200 rpm with overhead stirring.
• RuCI 2 (PNNP) catalyst 4a (3.7 mg, 50 ppm) in distilled and degassed THF (5 ml) is treated for 5 min with ultrasound to give a fine suspension, which is added to a suspension of KOMe (0.63 g, 9 mmol) in ethyl 10-undecenoate lb (19.2 g, 90 mmol) without additional solvent in a 120 ml Premex autoclave under argon. The autoclave is flushed three times with hydrogen and then heated at 100 °C under 50 bar hydrogen and 1200 rpm with overhead stirring. After 4 hours the heating is stopped and the pressure released. GC-analysis revealed 92% 10-undecenol 2a and 8% undecanol 2b.
• uCI 2 (PNNP) catalyst 4a (7.6 mg, 0.01%) in distilled and degassed THF (5 ml) is treated for 5 min with ultrasound to give a fine suspension, which is added to a suspension of KOMe (0.63 g, 9 mmol) in ethyl 9-decenoate 5a (18 g, 91 mmol) (P.Evans, M.Leffray, Tetrahedron 5 59, 7973 - 7981, 2003) in a 120 ml Premex autoclave under argon. The autoclave is flushed three times with hydrogen and then heated at 80 °C under 50 bar hydrogen and 1200 rpm with overhead stirring. After 3 hours GC-analysis revealed 86% dec-9-enol 6a, 10% decanol 6b and 3% of intermediate 7. CO/DB selectivity: 90:10.
• dec-9-enol 6a and decanol 6b were identical with the ones obtained from 10 commercial samples, e.g. RosalvaTM.
• the analytical data of 9-decenyl 9-decenoate 7 were identical with the ones known from the literature e.g. S. S. Narine et al., Ind. Eng. Chem. Res. 52, 2740, 2013.
• RuCI 2 (PNNP) catalyst 4a (21 mg, 0.01%) in styrene (12.75 g, 0.12mol) is treated for 5 min with ultrasound to give a fine suspension which is added to a suspension of KOMe (1.8 g, 25
• Undec-10-en-l-yl undec-10-enoate 3a was prepared as described by B. Kowalczyk et al., Angew. Chem. Int. Ed. 49, 5737,2010.
• Example 9 The reaction is carried out as described in Example 9 using catalyst 4a (4.2 mg, 0.02%) in styrene (1.25 g, 12 mmol) and KOMe (180 mg, 2,5 mmol) in undec-10-en-l-yl undec-10-enoate 3a (8.4 g, 25 mmol). After 8 hours an 98% conversion to 90% undec-10-enol 2a and 8% undecanol 2b was detected by GC. CO/DB selectivity 92:8.
• Example 11 preparation of substrate 5b see for example S. P. Morcillo et al., J. Org. Chem. 76, 2277,

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Inorganic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Materials Engineering (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Priority Applications (8)

Applications Claiming Priority (2)

Publications (1)

Family

ID=46458913

Family Applications (1)

Country Status (10)

Cited By (9)

Families Citing this family (1)

Citations (2)

Family Cites Families (3)

• 2012
  • 2012-05-16 GB GBGB1208589.0A patent/GB201208589D0/en not_active Ceased
• 2013
  • 2013-05-16 WO PCT/EP2013/060150 patent/WO2013171302A1/en not_active Ceased
  • 2013-05-16 BR BR112014028156A patent/BR112014028156A2/pt not_active Application Discontinuation
  • 2013-05-16 EP EP13724563.5A patent/EP2850050B1/en active Active
  • 2013-05-16 SG SG11201406503VA patent/SG11201406503VA/en unknown
  • 2013-05-16 MX MX2014012447A patent/MX363196B/es unknown
  • 2013-05-16 CN CN201380025207.8A patent/CN104284875B/zh active Active
  • 2013-05-16 JP JP2015512059A patent/JP6279552B2/ja active Active
  • 2013-05-16 US US14/398,076 patent/US9193651B2/en active Active
  • 2013-05-16 IN IN8413DEN2014 patent/IN2014DN08413A/en unknown

Patent Citations (2)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events